Lupin Lisinopril Tablets Recall: Metal Contaminant Risk
Lupin Pharmaceuticals recalls 10mg Lisinopril tablets due to metal contaminant in one tablet. Consumers should check product details and contact for remedy.
Lower-risk recall
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Contact the company
What happened, in plain English
Lupin Pharmaceuticals is recalling 10mg Lisinopril tablets (1000-count bottles) because a metal contaminant was found in one tablet. This could pose a risk if the contaminant causes injury during use. Read more at govinfonow.com/recall/39738-lupin-lisinopril-tablets-recall-metal-contaminant-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39738-lupin-lisinopril-tablets-recall-metal-contaminant-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1077-2018
Cite this page
“Lupin Lisinopril Tablets Recall: Metal Contaminant Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39738-lupin-lisinopril-tablets-recall-metal-contaminant-risk. Based on FDA recall #D-1077-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1077-2018%22&limit=1).
Why it’s dangerous
A metal contaminant was found in one tablet during a product complaint. This could potentially cause injury if the metal piece is ingested or causes a reaction in the body.
Who’s affected
People who have the 1000-count bottles of Lisinopril 10mg tablets, Rx only, manufactured by Lupin Pharmaceuticals in Baltimore, Maryland. Those with the specific lot number H800414 are most at risk.
How to tell if you have this one
Check for the product name 'Lisinopril Tablets USP, 10mg, 1000-count bottles', Rx only, manufactured by Lupin Pharmaceuticals in Baltimore, Maryland. Look for the lot number H800414 and expiration date 12/2019.
- Brand
Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Identify the product by checking the label for 'Lisinopril Tablets USP, 10mg, 1000-count bottles', Rx only, manufactured by Lupin Pharmaceuticals in Baltimore, Maryland.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this recall dangerous?
The recall is for a metal contaminant found in one tablet, which could pose a low risk if ingested. The hazard is not severe enough to require immediate stop use.
Similar recalls
Other Lupin Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1077-2018 (August 13, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1077-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.